Citius Pharmaceuticals (CTXR) EBIT Margin (2025 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly EBIT Margin came in at 1930.96% in Q1 2026, down 744.41% on a QoQ basis from 228.68% in Q4 2025.
Citius Pharmaceuticals (CTXR) EBIT Margin (2025 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 2 years of EBIT Margin data on file, last reported at 1930.96% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn | -785.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,930.96% |
| Dec 31, 2025 | -228.68% |